NM_002113.3:c.588A>G

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_002113.3(CFHR1):​c.588A>G​(p.Thr196Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.146 in 937,300 control chromosomes in the GnomAD database, including 51,416 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.24 ( 4307 hom., cov: 14)
Exomes 𝑓: 0.14 ( 47109 hom. )

Consequence

CFHR1
NM_002113.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.0760

Publications

4 publications found
Variant links:
Genes affected
CFHR1 (HGNC:4888): (complement factor H related 1) This gene encodes a secreted protein belonging to the complement factor H protein family. It binds to Pseudomonas aeruginosa elongation factor Tuf together with plasminogen, which is proteolytically activated. It is proposed that Tuf acts as a virulence factor by acquiring host proteins to the pathogen surface, controlling complement, and facilitating tissue invasion. Mutations in this gene are associated with an increased risk of atypical hemolytic-uremic syndrome. [provided by RefSeq, Oct 2009]
CFHR1 Gene-Disease associations (from GenCC):
  • dense deposit disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • age related macular degeneration 1
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • hemolytic uremic syndrome, atypical, susceptibility to, 1
    Inheritance: Unknown, AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 1-196828227-A-G is Benign according to our data. Variant chr1-196828227-A-G is described in ClinVar as Benign. ClinVar VariationId is 1283250.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.076 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 4307 Unknown,AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002113.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CFHR1
NM_002113.3
MANE Select
c.588A>Gp.Thr196Thr
synonymous
Exon 4 of 6NP_002104.2
CFHR1
NM_001379306.1
c.537A>Gp.Thr179Thr
synonymous
Exon 4 of 6NP_001366235.1
CFHR1
NM_001379307.1
c.426A>Gp.Thr142Thr
synonymous
Exon 4 of 6NP_001366236.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CFHR1
ENST00000320493.10
TSL:1 MANE Select
c.588A>Gp.Thr196Thr
synonymous
Exon 4 of 6ENSP00000314299.5
CFHR1
ENST00000699454.1
c.426A>Gp.Thr142Thr
synonymous
Exon 4 of 6ENSP00000514391.1
CFHR1
ENST00000699455.1
c.345A>Gp.Thr115Thr
synonymous
Exon 3 of 5ENSP00000514392.1

Frequencies

GnomAD3 genomes
AF:
0.244
AC:
20455
AN:
83704
Hom.:
4282
Cov.:
14
show subpopulations
Gnomad AFR
AF:
0.269
Gnomad AMI
AF:
0.104
Gnomad AMR
AF:
0.312
Gnomad ASJ
AF:
0.279
Gnomad EAS
AF:
0.388
Gnomad SAS
AF:
0.178
Gnomad FIN
AF:
0.192
Gnomad MID
AF:
0.234
Gnomad NFE
AF:
0.226
Gnomad OTH
AF:
0.233
GnomAD2 exomes
AF:
0.158
AC:
25983
AN:
164024
AF XY:
0.158
show subpopulations
Gnomad AFR exome
AF:
0.231
Gnomad AMR exome
AF:
0.199
Gnomad ASJ exome
AF:
0.275
Gnomad EAS exome
AF:
0.229
Gnomad FIN exome
AF:
0.110
Gnomad NFE exome
AF:
0.126
Gnomad OTH exome
AF:
0.155
GnomAD4 exome
AF:
0.137
AC:
116548
AN:
853482
Hom.:
47109
Cov.:
29
AF XY:
0.141
AC XY:
60287
AN XY:
428190
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.241
AC:
3303
AN:
13706
American (AMR)
AF:
0.269
AC:
7955
AN:
29610
Ashkenazi Jewish (ASJ)
AF:
0.251
AC:
3688
AN:
14704
East Asian (EAS)
AF:
0.353
AC:
8257
AN:
23376
South Asian (SAS)
AF:
0.189
AC:
9775
AN:
51636
European-Finnish (FIN)
AF:
0.158
AC:
5799
AN:
36606
Middle Eastern (MID)
AF:
0.103
AC:
336
AN:
3256
European-Non Finnish (NFE)
AF:
0.111
AC:
71650
AN:
645622
Other (OTH)
AF:
0.165
AC:
5785
AN:
34966
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.275
Heterozygous variant carriers
0
3026
6051
9077
12102
15128
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1102
2204
3306
4408
5510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.245
AC:
20513
AN:
83818
Hom.:
4307
Cov.:
14
AF XY:
0.242
AC XY:
9799
AN XY:
40532
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.269
AC:
4378
AN:
16266
American (AMR)
AF:
0.314
AC:
2505
AN:
7978
Ashkenazi Jewish (ASJ)
AF:
0.279
AC:
525
AN:
1880
East Asian (EAS)
AF:
0.389
AC:
1190
AN:
3062
South Asian (SAS)
AF:
0.179
AC:
432
AN:
2420
European-Finnish (FIN)
AF:
0.192
AC:
1321
AN:
6886
Middle Eastern (MID)
AF:
0.233
AC:
42
AN:
180
European-Non Finnish (NFE)
AF:
0.226
AC:
9794
AN:
43330
Other (OTH)
AF:
0.236
AC:
245
AN:
1036
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.294
Heterozygous variant carriers
0
860
1719
2579
3438
4298
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
184
368
552
736
920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.423
Hom.:
2111

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jul 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
7.4
DANN
Benign
0.70
PhyloP100
-0.076
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3201739; hg19: chr1-196797357; COSMIC: COSV57626314; COSMIC: COSV57626314; API